The people living with hiv antiretroviral therapy coverage in Yemen currently stands at 39%, which is 4% (11.4%) higher than 2021.
People living with HIV antiretroviral therapy coverage in Yemen
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Yemen
Antiretroviral therapy coverage
More indicators for Yemen
Male unintentional poisoning
2.2
+0.3
(2019)
Female wasting in children
14.8%
+3.1%
(2013)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar83
-intl dollar43
(2015)
Birth registration
30.7%
+13.6%
(2013)
Contraceptive modern method prevalence
29.2%
+9.6%
(2013)
Yemen Antiretroviral therapy coverage between 2000 and 2022
Period | Antiretroviral therapy coverage | Change |
---|---|---|
2022 | 39% | +4% |
2021 | 35% | +1% |
2020 | 34% | +2% |
2019 | 32% | +2% |
2018 | 30% | +3% |
2017 | 27% | +2% |
2016 | 25% | +4% |
2015 | 21% | +1% |
2014 | 20% | +4% |
2013 | 16% | +2% |
2012 | 14% | +1% |
2011 | 13% | +2% |
2010 | 11% | +4% |
2009 | 7% | +2% |
2008 | 5% | +3% |
2007 | 2% | +2% |
2006 | 0% | 0% |
2005 | 0% | 0% |
2004 | 0% | 0% |
2003 | 0% | 0% |
2002 | 0% | 0% |
2001 | 0% | 0% |
2000 | 0% |